The state of lumbar fusion extenders

Spine

Volumn 36, Issue 20, 2011, Pages

  Abdullah, Kalil G ^a,b   Steinmetz, Michael P ^a,b   Benzel, Edward C ^a,b   Mroz, Thomas E ^a,b  

^a CLEVELAND CLINIC LERNER COLLEGE OF MEDICINE   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

Author keywords

calcium phosphate; demineralized bone matrix; graft extenders; grafton; infuse; lumbar fusion; rhBMP 2; spine fusion

Indexed keywords

CALCIUM PHOSPHATE; CALCIUM SULFATE; HYDROXYAPATITE; RECOMBINANT BONE MORPHOGENETIC PROTEIN 2;

ARTICLE; BONE ALLOGRAFT; BONE MATRIX; BONE PROSTHESIS; CLINICAL EFFECTIVENESS; CLINICAL PRACTICE; DEMINERALIZED BONE MATRIX; HUMAN; LUMBAR FUSION EXTENDER; PRIORITY JOURNAL; SCOLIOSIS; SPINE FUSION; SYSTEMATIC REVIEW; TREATMENT OUTCOME;

BONE MORPHOGENETIC PROTEIN 2; BONE SUBSTITUTES; BONE TRANSPLANTATION; CALCIUM PHOSPHATES; HUMANS; INTERVERTEBRAL DISC DEGENERATION; LUMBAR VERTEBRAE; RECOMBINANT PROTEINS; SPINAL FUSION; SPONDYLOSIS; TRANSFORMING GROWTH FACTOR BETA;

EID: 80052655496     PISSN: 03622436     EISSN: 15281159     Source Type: Journal    
DOI: 10.1097/BRS.0b013e318209952b     Document Type: Article

References (31)

1. Kim DH, Rhim R, Li L, et al. Prospective study of iliac crest bone graft harvest site pain and morbidity. Spine J 2009;9:886-92.
2. Carragee EJ, Bono CM, Scuderi GJ. Pseudomorbidity in iliac crest bone graft harvesting: the rise of rhBMP-2 in short-segment posterior lumbar fusion. Spine J 2009;9:873-9.
3. Dimar JR II, Glassman SD, Burkus JK, et al. Two-year fusion and clinical outcomes in 224 patients treated with a single-level instrumented posterolateral fusion with iliac crest bone graft. Spine J 2009;9:880-5.
4. Resnick DK, Choudhri T F, Dailey AT, et al. Guidelines for the performance of fusion procedures for degenerative disease of the lumbar spine. Part 1: Introduction and methodology. J Neurosurg Spine 2005;2:637-8.
5. Guidelines for the management of severe head injury. Introduction. J Neurotrauma 1996;13:643-5.
6. Cammisa FP Jr, Lowery G, Garfin SR, et al. Two-year fusion rate equivalency between grafton DBM gel and autograft in posterolateral spine fusion: a prospective controlled trial employing a side-by-side comparison in the same patient. Spine (Phila Pa 1976) 2004;29:660-6. (Pubitemid 38339563)
7. Schizas C, Triantafyllopoulos D, Kosmopoulos V, et al. Postero-lateral lumbar spine fusion using a novel demineralized bone matrix: a controlled case pilot study. Arch Orthop Trauma Surg 2008;128:621-5.
8. Delecrin J, Takahashi S, Gouin F, et al. A synthetic porous ceramic as a bone graft substitute in the surgical management of scoliosis: a prospective, randomized study. Spine (Phila Pa 1976) 2000;25:563-9. (Pubitemid 30158214)
9. Lerner T, Bullmann V, Schulte TL, et al. A level-1 pilot study to evaluate of ultraporous beta-tricalcium phosphate as a graft extender in the posterior correction of adolescent idiopathic scoliosis. Eur Spine J 2009;18:170-9.
10. Dai LY, Jiang LS. Single-level instrumented posterolateral fusion of lumbar spine with beta-tricalcium phosphate versus autograft: A prospective, randomized study with 3-year follow-up. Spine (Phila Pa 1976) 2008;33:1299-304.
11. Epstein NE. Beta tricalcium phosphate: Observation of use in 100 posterolateral lumbar instrumented fusions. Spine J 2009;9:630-8.
12. Muschik M, Ludwig R, Halbhubner S, et al. Beta-tricalcium phosphate as a bone substitute for dorsal spinal fusion in adolescent id-iopathic scoliosis: Preliminary results of a prospective clinical study. Eur Spine J 2001;10(suppl 2):S178-84. (Pubitemid 32999821)
13. Meadows GR. Adjunctive use of ultraporous beta-tricalcium phosphate bone void filler in spinal arthrodesis. Orthopedics 2002;25:S579-84. (Pubitemid 36395027)
14. Gunzburg R, Szpalski M. Use of a novel beta-tricalcium phosphate-based bone void filler as a graft extender in spinal fusion surgeries. Orthopedics 2002;25:S591-5. (Pubitemid 36395029)
15. Dawson E, Bae HW, Burkus JK, et al. Recombinant human bone morphogenetic protein-2 on an absorbable collagen sponge with an osteoconductive bulking agent in posterolateral arthrodesis with instrumentation. A prospective randomized trial. J Bone Joint Surg Am 2009;91:1604-13.
16. Dimar JR II, Glassman SD, Burkus JK, et al. Clinical and radio-graphic analysis of an optimized rhBMP-2 formulation as an auto-graft replacement in posterolateral lumbar spine arthrodesis. J Bone Joint Surg Am 2009;91:1377-86.
17. Meisel HJ, Schnoring M, Hohaus C, et al. Posterior lumbar inter-body fusion using rhBMP-2. Eur Spine J. 2008;17:1735-44.
18. Mulconrey DS, Bridwell KH, Flynn J, et al. Bone morphogenetic protein (RhBMP-2) as a substitute for iliac crest bone graft in multilevel adult spinal deformity surgery: minimum two-year evaluation of fusion. Spine (Phila Pa 1976) 2008;33:2153-9.
19. Katayama Y, Matsuyama Y, Yoshihara H, et al. Clinical and radio-graphic outcomes of posterolateral lumbar spine fusion in humans using recombinant human bone morphogenetic protein-2: an average five-year follow-up study. Int Orthop 2009;33:1061-7.
20. Agarwal R, Williams K, Umscheid CA, et al. Osteoinductive bone graft substitutes for lumbar fusion: a systematic review. J Neuro-surg Spine 2009;11:729-40.
21. Singh K, Smucker JD, Gill S, et al. Use of recombinant human bone morphogenetic protein-2 as an adjunct in posterolateral lumbar spine fusion: a prospective CT-scan analysis at one and two years. J Spinal Disord Tech 2006;19:416-23. (Pubitemid 44197593)
22. Stambough JL, Clouse EK, Stambough JB. Instrumented one and two level posterolateral fusions with recombinant human bone morphogenetic protein-2 and allograft: a computed tomography study. Spine (Phila Pa 1976) 2010;35:124-9.
23. Thalgott JS, Giuffre JM, Fritts K, et al. Instrumented posterolateral lumbar fusion using coralline hydroxyapatite with or without demineral-ized bone matrix, as an adjunct to autologous bone. Spine J 2001;1: 131-7. (Pubitemid 33628836)
24. Korovessis P, Koureas G, Zacharatos S, et al. Correlative radiological, self-assessment and clinical analysis of evolution in instrumented dorsal and lateral fusion for degenerative lumbar spine disease. autograft versus coralline hydroxyapatite. Eur Spine J 2005;14:6 30-8. (Pubitemid 41414079)
25. Chen CL, Liu CL, Sun SS, et al. Posterolateral lumbar spinal fusion with autogenous bone chips from laminectomy extended with Os-teoSet. J Chin Med Assoc 2006;69:581-4.
26. Chang CH, Lin MZ, Chen YJ, et al. Local autogenous bone mixed with bone expander: an optimal option of bone graft in single-segment posterolateral lumbar fusion. Surg Neurol 2008;70(suppl 1):S1:47-9; discussion S1:49.
27. Niu CC, Tsai TT, Fu TS, et al. A comparison of posterolateral lumbar fusion comparing autograft, autogenous laminectomy bone with bone marrow aspirate, and calcium sulphate with bone marrow aspirate: a prospective randomized study. Spine (Phila Pa 1976) 2009;34:2715-9.
28. Wetzel FT. Investigation of graft extenders in lumbar fusions: methodological and clinical concerns for current and future studies. Spine J 2009;9:670-1.
29. Vaidya R, Weir R, Sethi A, et al. Interbody fusion with allograft and rhBMP-2 leads to consistent fusion but early subsidence. J Bone Joint Surg Br 2007;89:342-5. (Pubitemid 46563910)
30. Smoljanovic T, Bojanic I, Delimar D. Adverse effects of posterior lumbar interbody fusion using rhBMP-2. Eur Spine J 2009;18:920-3; author reply 924.
31. Chen NF, Smith ZA, Stiner E, et al. Symptomatic ectopic bone formation after off-label use of recombinant human bone morphoge-netic protein-2 in transforaminal lumbar interbody fusion. J Neuro-surg Spine 2010;12:40-6.